In the meantime, H.C. Wainwright downgraded its BioAtla Inc [BCAB] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in mid September with a ‘”a Mkt outperform”‘ rating. Credit Suisse also remained covering BCAB and has decreased its forecast on May 05, 2022 with a “Neutral” recommendation from previously “an Outperform” rating. H.C. Wainwright started covering the stock on March 21, 2022. It rated BCAB as “a Buy”.
Price Performance Review of BCAB
On Tuesday, BioAtla Inc [NASDAQ:BCAB] saw its stock jump 11.35% to $0.50. Over the last five days, the stock has gained 43.18%. BioAtla Inc shares have fallen nearly -16.20% since the year began. Nevertheless, the stocks have fallen -77.98% over the past one year. While a 52-week high of $3.53 was reached on 01/06/25, a 52-week low of $0.24 was recorded on 03/04/25. SMA at 50 days reached $0.3535, while 200 days put it at $1.1822.
Levels Of Support And Resistance For BCAB Stock
The 24-hour chart illustrates a support level at 0.4403, which if violated will result in even more drops to 0.3851. On the upside, there is a resistance level at 0.5384. A further resistance level may holdings at 0.5813. The Relative Strength Index (RSI) on the 14-day chart is 73.13, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0977, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 11.62%. Stochastics %K at 84.84% indicates the stock is a selling.
How much short interest is there in BioAtla Inc?
A steep rise in short interest was recorded in BioAtla Inc stocks on 2025-04-15, dropping by -0.17 million shares to a total of 4.06 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 4.22 million shares. There was a decline of -4.08%, which implies that there is a negative sentiment for the stock.